Zoetis, Inc. (ZTS)
72.97
+0.11
(+0.15%)
USD |
NYSE |
Sep 11, 16:00
73.12
+0.15
(+0.21%)
After-Hours: 20:00
Zoetis Market Cap : 30.22B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 30.22B |
| September 10, 2026 | 30.18B |
| September 09, 2026 | 30.36B |
| September 08, 2026 | 30.47B |
| September 04, 2026 | 31.40B |
| September 03, 2026 | 31.60B |
| September 02, 2026 | 31.55B |
| September 01, 2026 | 31.99B |
| August 31, 2026 | 31.93B |
| August 28, 2026 | 32.03B |
| August 27, 2026 | 31.07B |
| August 26, 2026 | 32.11B |
| August 25, 2026 | 32.01B |
| August 24, 2026 | 31.96B |
| August 21, 2026 | 32.19B |
| August 20, 2026 | 31.07B |
| August 19, 2026 | 31.76B |
| August 18, 2026 | 30.63B |
| August 17, 2026 | 30.22B |
| August 14, 2026 | 30.56B |
| August 13, 2026 | 31.41B |
| August 12, 2026 | 30.46B |
| August 11, 2026 | 31.21B |
| August 10, 2026 | 30.99B |
| August 07, 2026 | 30.09B |
| Date | Value |
|---|---|
| August 06, 2026 | 32.00B |
| August 05, 2026 | 30.81B |
| August 04, 2026 | 31.49B |
| August 03, 2026 | 32.41B |
| July 31, 2026 | 32.49B |
| July 30, 2026 | 31.96B |
| July 29, 2026 | 32.76B |
| July 28, 2026 | 32.58B |
| July 27, 2026 | 32.33B |
| July 24, 2026 | 31.67B |
| July 23, 2026 | 31.35B |
| July 22, 2026 | 31.19B |
| July 21, 2026 | 31.67B |
| July 20, 2026 | 32.03B |
| July 17, 2026 | 32.18B |
| July 16, 2026 | 32.33B |
| July 15, 2026 | 31.33B |
| July 14, 2026 | 31.14B |
| July 13, 2026 | 31.69B |
| July 10, 2026 | 31.76B |
| July 09, 2026 | 31.56B |
| July 08, 2026 | 31.57B |
| July 07, 2026 | 32.07B |
| July 06, 2026 | 31.70B |
| July 02, 2026 | 31.44B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 157.98B |
| Elanco Animal Health, Inc. | 11.57B |
| Boston Scientific Corp. | 62.18B |
| Eli Lilly & Co. | 1.050T |
| Merck & Co., Inc. | 355.31B |
Market Cap Related Metrics
| PE Ratio | 12.00 |
| PS Ratio | 3.301 |
| PEG Ratio | 2.208 |
| Price to Book Value | 9.60 |
| Price to Free Cash Flow | 13.28 |
| Price | 72.97 |
| Earnings Yield | 8.33% |
| PEGY Ratio | 1.446 |
| Operating PE Ratio | 8.767 |
| Normalized PE Ratio | 11.61 |